Furagīns 50 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

furagīns 50 mg tabletes

olainfarm, as, latvia - furagīns - tablete - 50 mg

Nozepam 10 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

nozepam 10 mg tabletes

olainfarm, as, latvia - oksazepāms - tablete - 10 mg

Rinvoq Avrupa Birliği - Letonca - EMA (European Medicines Agency)

rinvoq

abbvie deutschland gmbh & co. kg - upadacitinib - artrīts, reimatoīds - imūnsupresanti - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Magromag 100 mg modificētās darbības cietās kapsulas Letonya - Letonca - Zāļu valsts aģentūra

magromag 100 mg modificētās darbības cietās kapsulas

olainfarm, as, latvia - nitrofurantoīns - modificētās darbības kapsula, cietā - 100 mg

Adrovance Avrupa Birliği - Letonca - EMA (European Medicines Agency)

adrovance

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporoze, pēcmenopauzes - zāles kaulu slimību ārstēšanai - pēcmenopauzes osteoporozes ārstēšana pacientiem ar vitamīna d trūkuma risku. adrovance samazina mugurkaula un gūžas kaula lūzumu.

Paxifor 20 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

paxifor 20 mg tabletes

grindeks, as, latvija - aripiprazols - tabletes - 20 mg

Clozapine Olainfarm 25 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

clozapine olainfarm 25 mg tabletes

olainfarm, as, latvija - klozapīns - tablete - 25 mg

Clozapine Olainfarm 100 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

clozapine olainfarm 100 mg tabletes

olainfarm, as, latvija - klozapīns - tablete - 100 mg

Paxifor 15 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

paxifor 15 mg tabletes

grindeks, as, latvia - aripiprazols - tablete - 15 mg

Paxifor 30 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

paxifor 30 mg tabletes

grindeks, as, latvija - aripiprazols - tabletes - 30 mg